Target Name: GATA6-AS1
NCBI ID: G100128893
Review Report on GATA6-AS1 Target / Biomarker Content of Review Report on GATA6-AS1 Target / Biomarker
GATA6-AS1
Other Name(s): Locus5689 | locus5689 | BM742401 | GATA6 antisense RNA 1 (head to head)

GATA6-AS1: A Potential Drug Target and Biomarker

GATA6 (Gene Expression Analysis Tool 6) is a gene expression profiling tool that has been widely used to study gene regulation in various organisms, including humans. GATA6 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

GATA6 is a key regulator of gene expression and has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. GATA6 has been shown to regulate the expression of target genes that are involved in cell signaling pathways, such as the TGF-β pathway, which plays a role in cell growth, differentiation, and survival.

In addition to its role in cell signaling pathways, GATA6 has also been shown to play a role in the regulation of cellular immortalization. GATA6 has been shown to promote the immortalization of cancer cells by regulating the expression of genes involved in cell cycle progression and apoptosis.

GATA6 has also been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. GATA6 has been shown to regulate the expression of genes involved in the production of neurotransmitters, such as dopamine and serotonin, which are involved in the regulation of mood, appetite, and movement.

In addition to its role in neurodegenerative diseases, GATA6 has also been shown to be involved in the regulation of psychiatric disorders, including depression and anxiety. GATA6 has been shown to regulate the expression of genes involved in the production of neurotransmitters, such as dopamine and serotonin, which are involved in the regulation of mood, appetite, and movement.

GATA6 has also been shown to play a role in the regulation of inflammation. GATA6 has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾, which are involved in the regulation of inflammation and immune responses.

GATA6 has also been shown to play a role in the regulation of cellular aging. GATA6 has been shown to regulate the expression of genes involved in the production of reactive oxygen species (ROS), which are involved in the regulation of cellular aging.

In conclusion, GATA6 is a gene expression profiling tool that has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. GATA6 has also been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the role of GATA6 in these diseases and to develop effective treatments.

Protein Name: GATA6 Antisense RNA 1 (head To Head)

The "GATA6-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GATA6-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK | GCKR | GCLC | GCLM | GCM1 | GCM2 | GCN1 | GCNA | GCNT1 | GCNT1P3 | GCNT2 | GCNT3 | GCNT4 | GCNT7 | GCOM1 | GCSAM | GCSAML | GCSAML-AS1 | GCSH | GCSHP3 | GCSIR | GDA | GDAP1 | GDAP1L1 | GDAP2 | GDE1 | GDF1 | GDF10 | GDF11 | GDF15 | GDF2 | GDF3 | GDF5 | GDF6 | GDF7 | GDF9 | GDI1 | GDI2 | GDI2P1 | GDNF | GDNF Family Receptor alpha | GDNF-AS1 | GDPD1 | GDPD2 | GDPD3 | GDPD4 | GDPD5 | GDPGP1 | GEM | GEMIN2 | GEMIN4 | GEMIN5 | GEMIN6 | GEMIN7 | GEMIN8 | GEMIN8P1 | GEMIN8P4 | GEN1 | general transcription factor IIF (TFIIF) | General transcription factor IIH